Addressing Optic Neuritis, Neuromyelitis Optica and Multiple Sclerosis

By promoting neuroprotection and remyelination

Promoting Neuroprotection

First-in-class SGK agonists for rare ophthalmological conditions

Science

first-in-class small molecules promoting neuroprotection and remyelination.
Read more

Focus

Rare ophthalmological conditions: optic neuritis and neuromyelitis optica.
Read more

News

Finding new drugs through systems medicine: CombiMS project led by Bionure is reaching its end.